ABDELALL, Nesrine Gamal Mohamad
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 465
EU - Europa 200
AS - Asia 40
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 464
SE - Svezia 114
IE - Irlanda 28
HK - Hong Kong 25
DE - Germania 17
CN - Cina 12
GB - Regno Unito 12
BG - Bulgaria 11
IT - Italia 7
AT - Austria 2
CL - Cile 2
FI - Finlandia 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CA - Canada 1
DK - Danimarca 1
ES - Italia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 710
Salva come PNG Salva come JPEG
Città #
Chandler 113
Nyköping 64
Ashburn 57
Fairfield 51
Dublin 28
Hong Kong 24
Cambridge 23
Wilmington 22
Houston 15
Seattle 15
Woodbridge 15
Ann Arbor 11
Princeton 11
San Diego 11
Sofia 11
Grafing 10
New York 8
Beijing 5
London 5
Des Moines 4
Shanghai 4
Falls Church 3
Acton 2
Augusta 2
Bremen 2
Helsinki 2
Negrar 2
San Francisco 2
Vienna 2
Ardabil 1
Bologna 1
Central 1
Chiswick 1
Groningen 1
Gunzenhausen 1
Hanover 1
Hounslow 1
Milan 1
Norwalk 1
San Mateo 1
Tokyo 1
Toronto 1
Totale 537
Salva come PNG Salva come JPEG
Nome #
Adaptive response in Hepatitis B virus infection 82
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients 72
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 70
Grazoprevir/elbasvir fixed-dose combination for hepatitis C 68
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 68
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 66
ABT-450: A novel agent for the treatment of CHC genotype 1: Focus on treatment-experienced patients 64
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 61
Safety and efficacy of once daily ledipasvir/sofosbuvir fixed-dose combination in patients with chronic hepatitis C 59
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 58
Working together to tackle HCV infection: Ombitasvir/paritaprevir/ritonavir and dasabuvir combination 55
Totale 723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 56 1 47 1
2021/2022212 11 0 10 16 11 23 5 18 44 15 34 25
2022/2023300 56 50 13 28 32 35 12 22 39 1 3 9
2023/2024106 5 5 4 22 31 20 7 4 7 1 0 0
Totale 723